Keshoofi, Pedram
Schindler, Philipp
Rennebaum, Florian
Cordes, Friederike
Morgul, Haluk
Wildgruber, Moritz
Heinzow, Hauke S.
Pascher, Andreas
Schmidt, Hartmut H.
Hüsing-Kabar, Anna
Praktiknjo, Michael
Trebicka, Jonel
Seifert, Leon Louis
Funding for this research was provided by:
Universitätsklinikum Münster
Article History
Received: 12 November 2023
Accepted: 16 April 2024
First Online: 25 April 2024
Declarations
:
: The retrospective study has been carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) and was approved by the Ethics Committee of the University of Münster, Germany (File number 2018-378-f-S). The local institutional review board approved the study. Written informed consent of patients was waived by the Ethics Committee of the University of Münster, Germany for retrospective data analysis. STROBE cohort reporting guidelines were used.
: Not applicable.
: JT has received speaking and/or consulting fees from Versantis, Gore, Boehringer-Ingelheim, Falk, Grifols, Genfit and CSL BehringLLS has received speaking fees from Gilead. Pedram Keshoofi, Florian Rennebaum, Philipp Schindler, Friederike Cordes, Haluk Morgul, Moritz Wildgruber, Hauke S. Heinzow, Andreas Pascher, Hartmut H. Schmidt, Anna Hüsing-Kabar, Michael Praktiknjo, declare that they have no conflict of interest.
: Preliminary selected data of this study have previously been presented at the Viszeralmedizin 2022 Conference of the German Society for Digestive and Metabolic Diseases (DGVS) in Hamburg and the United European Gastroenterology (UEG) Week 2022 in Vienna.